Back to Search
CAITLIN OTTO, PHD
PHD
Clinical Laboratory Director (Non-physician)
NPI: 1922678861Individual
Specialties, Licenses & Credentials
Clinical Laboratory Director (Non-physician)Primary
Technician, Pathology — Clinical Laboratory Director, Non-physician
Code: 247ZC0005X
OTTOC1(NY)
Research & Publications (20)
GPR30 does not mediate estrogenic responses in reproductive organs in mice.
PMID 18799753·Biol Reprod·2009
7-preclinical
In vivo characterization of estrogen receptor modulators with reduced genomic versus nongenomic activity in vitro.
PMID 18606537·J Steroid Biochem Mol Biol·2008
7-preclinical
G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol.
PMID 18566127·Endocrinology·2008
7-preclinical
Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides.
PMID 18447912·BMC Cancer·2008
4-observational
Comparative analysis of the uterine and mammary gland effects of drospirenone and medroxyprogesterone acetate.
PMID 18420741·Endocrinology·2008
4-observational
In vivo characterization of progestins with reduced non-genomic activity in vitro.
PMID 18540572·Ernst Schering Found Symp Proc·2007
6-review
Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
PMID 17935245·J Clin Apher·2007
4-observational
Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia.
PMID 17530469·Acta Diabetol·2007
2-rct
Exploiting nongenomic estrogen receptor-mediated signaling for the Development of pathway-selective Estrogen receptor ligands.
PMID 17824177·Ernst Schering Found Symp Proc·2006
6-review
Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels.
PMID 16682836·J Endocrinol Invest·2006
8-other
MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
PMID 16647463·Transplant Proc·2006
7-preclinical
Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID mice.
PMID 16404231·Nucl Med Commun·2006
7-preclinical
Pulmonary hypertension and right heart failure in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice.
PMID 15520307·Circulation·2004
7-preclinical
Long-term reduction of C-reactive protein concentration by regular LDL apheresis.
PMID 15135264·Atherosclerosis·2004
4-observational
Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia.
PMID 14678426·Artif Organs·2003
4-observational
Mutations in the C3 region of human and simian immunodeficiency virus envelope have differential effects on viral infectivity, replication, and CD4-dependency.
PMID 14585332·Virology·2003
7-preclinical
Prolongation of small bowel allograft survival with a sequential therapy consisting of a synthetic MHC class II peptide and temporarily low-dose cyclosporine A.
PMID 12368040·Hum Immunol·2002
7-preclinical
Investigation of the immunosuppressive potential of anti-CD28 antibodies for selective inhibition of the T-cell mediated alloresponse.
PMID 12270444·Transplant Proc·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 140 58TH ST. BUILDING A, SUITE 8J
BROOKLYN, NY 11220 - Phone
- (888) 685-2885
Quick Facts
- NPI
- 1922678861
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile